Cardiac safety of nonpegylated liposomal doxorubicin in patients with advanced breast cancer treated with myocet plus vinorelbine or myocet plus cyclophosphamide in a randomized phase II trial.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 1119-1119
Author(s):  
V. Lorusso ◽  
G. A. De Giorgi ◽  
M. Ciccarese ◽  
V. E. Chiuri ◽  
F. Giotta ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Phase Ii Trial ◽  
Advanced Breast ◽  
Cardiac Safety ◽  
Randomized Phase Ii

A randomized phase II trial of aminoglutethimide and hydrocortisone versus combined aminoglutethimide, hydrocortisone and fluoxymesterone in advanced breast cancer

1987 ◽  
Vol 9 (3) ◽  
pp. 217-220 ◽  
Author(s):  
Constantine S. Gennatas ◽  
Angelos Kalovidouris ◽  
George A. Paraskevas ◽  
John Kouvaris ◽  
Demetrios Trichopoulos ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast ◽  
Randomized Phase Ii
Sign in / Sign up

Export Citation Format

Share Document